Bactocillin® is a food supplement containing the probiotic strain Bifidobacterium breve PRL2020, the only bacterial strain available on worldwide market with demonstrated resistance to high concentrations of the antibiotics Amoxicillin and Amoxicillin/Clavulanic acid.
This unique feature allows Bactocillin® to be administered simultaneously with these two antibiotics, with the aim of counteracting the re-emergence of pathogenic bacteria and consequently reducing the incidence of diarrhoea and intestinal disorders during antibiotic treatment, while preventing post-antibiotic relapses. The genome of B. breve PRL2020 has been fully sequenced and its safety for use has been established.